Sunvozertinib inhibited EGFR ex20ins at half the inhibitory concentration (50%) in tumor cell lines expressing EGFR L8s8R, Exonl9del, L858R/T790M, and multiple ex20ins. The gene discussed is EGFR; the disease is neoplasm.